Gene therapy in the central nervous system: direct versus indirect gene delivery

Journal of Neuroscience Research
J L Ridet, A Privat

Abstract

Over the last decade, the combination of molecular biology and cell transplantation techniques has given rise to a powerful method for gene therapy. The implantation of genetically modified cultured cells has been extensively used in the central nervous system (CNS) in various experimental models of neurologic disorders. More recently, viral and chemical methods have been developed to further efforts to shuttle transgenes into the relatively inaccessible brain. Adenoviral and liposomal synthetic vectors carry transgenes into neural tissue in situ and are beginning to show promise as new methods for CNS therapy.

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y DaiI M Verma
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R StriblingR Debs
Mar 23, 1990·Science·J A WolffP L Felgner
Feb 1, 1990·Trends in Neurosciences·H G Kuypers, G Ugolini
Aug 1, 1991·Trends in Neurosciences·F H GageL J Fisher
Oct 1, 1991·Current Opinion in Neurobiology·F H GageL J Fisher
Nov 1, 1990·Journal of Pharmaceutical Sciences·K MaruyamaL Huang
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K MaruyamaL Huang
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·N Benvenisty, L Reshef
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·C NicolauM F Juhel
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P SorianoC Nicolau
Jan 1, 1995·Nature Medicine·R G Crystal
Dec 1, 1994·Current Opinion in Biotechnology·E M Gordon, W F Anderson
Dec 1, 1994·Current Opinion in Biotechnology·B C Trapnell, M Gorziglia
Dec 1, 1994·Current Opinion in Biotechnology·F D Ledley
Feb 1, 1995·Current Opinion in Neurobiology·J Y Kuwada
Oct 1, 1994·Current Opinion in Neurobiology·L J Fisher, J Ray
Mar 3, 1995·Science·D D Lasic, D Papahadjopoulos
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J S RemyJ P Behr
Jun 13, 1994·Brain Research·V RidouxG Le Gal La Salle
Nov 1, 1993·Archives of Neurology·S T Suhr, F H Gage
Oct 1, 1993·Current Opinion in Neurobiology·J A Wolff
Jul 1, 1993·Physiological Reviews·L J Fisher, F H Gage
Nov 1, 1993·Journal of Neurosurgery·D BarbaF H Gage
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J RayF H Gage

❮ Previous
Next ❯

Citations

Dec 14, 1999·Journal of Neuroscience Methods·B WiesenhoferC Humpel
Sep 1, 1997·Neurochemistry International·B WeissS P Zhang
Jul 14, 1999·Neurochemistry International·A ThorsellM Heilig
Feb 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·S C BarsoumP L Chang
Jan 6, 1999·The European Journal of Neuroscience·M P MartresB Giros
Mar 15, 2002·Journal of Neurotrauma·Manuel GaviriaAlain Privat
Apr 20, 2010·International Journal of Radiation Biology·Mohamed AmmariRené De Seze
Apr 22, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohamed AmmariRené de Seze

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Current Opinion in Neurobiology
L J Fisher, J Ray
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
D SampathJ R Perez-Polo
© 2021 Meta ULC. All rights reserved